FDA Inspection 1169025 — HCSC Blood Center

HCSC Blood Center — FEI 2577633

The FDA completed an inspection of HCSC Blood Center on April 27, 2022 in Reading, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 27, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Reading, PA (United States)